Discovery of a NADPH oxidase inhibitor, (E)-3-cyclohexyl-5-(4-((2-hydroxyethyl)(methyl)amino)benzylidene)-1-methyl-2-thioxoimidazolidin-4-oneone, as a novel therapeutic for Parkinson's disease

Post time 2024-5-6 02:00:53

journal：European Journal of Medicinal Chemistry

Authors：Seunghwan Shim; Da Un Jeong; Hyemi Kim; Chae Yun Kim; Hyejun Park; Yinglan Jin; Kyung Min Kim; Hwa Jeong Lee; Dong Hwan Kim; Yun Soo Bae; Yongseok Choi

Published date：2022-12-

DOI：10.1016/j.ejmech.2022.114854

PDF link：https://www.sciencedirect.com/sc ... 223523422007565/pdf

Article link：http://dx.doi.org/10.1016/j.ejmech.2022.114854

Article Source：Elsevier BV。

Remark：

Post time 2024-5-6 02:00:54

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2024-5-6 02:44:37

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Elsevier] Discovery of a NADPH oxidase inhibitor, (E)-3-cyclohexyl-5-(4-((2-hydroxyethyl)(methyl)amino)benzylidene)-1-methyl-2-thioxoimidazolidin-4-oneone, as a novel therapeutic for Parkinson's disease

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today